Aptevo Therapeutics (APVO) Cost of Revenue (2015 - 2019)
Aptevo Therapeutics (APVO) reported Cost of Revenue of $6.14 million for Q4 2019, up 37.5% from $4.46 million a year earlier and up 55.0% from the prior quarter.
Powered by 
Analysis
Aptevo Therapeutics (APVO) Cost of Revenue (2015 - 2019) Analysis & Trends
For FY2019, Aptevo Therapeutics posted Cost of Revenue of $19.93 million, up 77.7% from FY2018.
- Cost of Revenue has a four-year compound annual growth rate of 4.2% (FY2015 to FY2019).
- By year, Cost of Revenue came in at $11.21 million in FY2018 (+123.8%), $5.01 million in FY2017 (-59.8%), $12.47 million in FY2016 (-26.4%) and $16.93 million in FY2015.
- The Q4 2019 figure ranks as the highest quarterly Cost of Revenue since Q2 2016.
- Year over year, Cost of Revenue has now increased in each of the last six quarters, with growth averaging 90.7% over the last eight quarters.
- The high point for year-over-year Cost of Revenue in five years was Q1 2018 (growth of 265.0%); the low point was Q1 2017 (a decline of 86.2%).
- Per Business Quant data, the three quarters before Q4 2019 came in at $3.96 million (Q3 2019), $5.99 million (Q2 2019) and $3.85 million (Q1 2019).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 8.05 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.09 Bn |
| 10 | Aptevo Therapeutics | 2.50 Mn | -64.50 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2019 | 6.14 Mn |
| Sep 30, 2019 | 3.96 Mn |
| Jun 30, 2019 | 5.99 Mn |
| Mar 31, 2019 | 3.85 Mn |
| Dec 31, 2018 | 4.46 Mn |
| Sep 30, 2018 | 2.44 Mn |
| Jun 30, 2018 | 2.53 Mn |
| Mar 31, 2018 | 1.78 Mn |
| Dec 31, 2017 | 1.90 Mn |
| Sep 30, 2017 | 1.87 Mn |
| Jun 30, 2017 | 5.90 Mn |
| Mar 31, 2017 | 488,000.00 |
| Dec 31, 2016 | 5.08 Mn |
| Sep 30, 2016 | 4.11 Mn |
| Jun 30, 2016 | 6.54 Mn |
| Mar 31, 2016 | 3.53 Mn |
| Dec 31, 2015 | 5.24 Mn |
| Sep 30, 2015 | 3.53 Mn |
| Jun 30, 2015 | 4.44 Mn |
API Access
Aptevo Therapeutics Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=APVO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "APVO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=APVO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();